TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Seven Bridges Stock

Seven Bridges Stock

sevenbridges.comHealthcare / BioTech & PharmaFounded: 2009Funding to Date: $45MM

Seven Bridges is a provider of unified bioinformatics solutions accelerating precision medicine by enabling the understanding of biomedical data.

Buy or sell Seven Bridges stockLearn more about Seven Bridges IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Seven Bridges, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Seven Bridges’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Seven Bridges.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Seven Bridges investors also invested in these private companies

Kryssen Capital

Team

Management Team

Igor Bogicevic
Co-Founder and Chief Technology Officer
Mladen Srdic
Chief Technology Officer
Milan Mitrovic
Chief Product Officer
James Sietstra
President and Board Member
Robert Shay
Chief Financial Officer
Brian Castagna
Chief Information Security Officer
Brandi Davis-Dusenbery Ph.D
Chief Scientific Officer
Mike Bigda
Chief Operating Officer
William Moss
Chief Executive Officer
Bruce Press
Chief Revenue Officer

Board Members

James Sietstra

Frequently Asked Questions About Seven Bridges’ Stock

plusminus
Can you buy Seven Bridges’ stock?
Seven Bridges is not publicly traded on NYSE or NASDAQ in the U.S. To buy Seven Bridges’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Seven Bridges’ stock?
Yes, you can sell stock of a private company like Seven Bridges. Forge can help you sell your Seven Bridges stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Seven Bridges’ stock price?
Seven Bridges is a privately held company and therefore does not have a public stock price. However, you may access Seven Bridges’ private market stock price with Forge Data.
plusminus
What is Seven Bridges’ stock ticker symbol?
Seven Bridges does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Seven Bridges in the BioTech & Pharma sector

Egenesis

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$387.57MM

Colossal Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.01B

Prime Medicine

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.23B

ADARx Pharmaceuticals

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$827.77MM

Altos Labs

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$6.33B

Tempus

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$8.7B

Cytonics

Sector
Healthcare / BioTech & Pharma
 
 

Pendulum Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$308.05MM

AI Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$110MM

News Highlights

Genomeweb 12/16/2021
Seven Bridges Genomics to Foster Partnerships Between Health Systems, Pharmas With New Subsidiary
The Unified Patient Network expects pharmaceutical companies to sponsor whole-genome sequencing for patients from health systems for research and clinical purposes.
Genomeweb 04/27/2021
Seven Bridges Raises $15M in First Closing of Series C
Geekwire 09/11/2018
Seven Bridges, E-Nios Partner to Automate Biomarker Extraction From NGS Data
With their strategic partnership, the bioinformatics firms seek to "break the biomarker bottleneck" that is holding back the potential of multi-omics research.

Trending Companies

Frequently Asked Questions

Updated on: Apr 25, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.